Chris Compton

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Steven Pascoe, Neil Barnes, Guy Brusselle et al. · The Lancet Respiratory Medicine · 2019 · 225 citations · Full text

Allergy, Advanced Lung Disease, Blood Eosinophils +5

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

François Maltais, Leif Bjermer, Edward Kerwin et al. · Respiratory Research · 2019 · 115 citations · Full text

INTREPID: single-<i>versus</i>multiple-inhaler triple therapy for COPD in usual clinical practice

David Halpin, Sally Worsley, Afisi Ismaila et al. · ERJ Open Research · 2021 · 63 citations · Full text

Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

David Halpin, Kieran Rothnie, Victoria Banks et al. · International Journal of COPD · 2022 · 44 citations · Full text

Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Sandeep Bansal, Martin Anderson, Antonio Anzueto et al. · npj Primary Care Respiratory Medicine · 2021 · 40 citations · Full text